This inventor holds 14 USPTO granted patents and 4 published patent applications. Top assignees: Northwestern University, University of Pennsylvania, Other. Active years: 1998-2020.
Location History:
- Philadelphia, PA (US) (1998)
- Chicago, IL (US) (2000 - 2020)
Company Filing History:


Years Active: 1998-2020
Title: The Innovative Contributions of Inventor Eva E Redei
Introduction
Eva E Redei is a distinguished inventor based in Chicago, Illinois, known for her significant contributions to the field of mental health research. With 14 patents to her name, her innovative work aims to enhance the diagnosis and treatment of depressive disorders, showcasing her commitment to improving mental health outcomes.
Latest Patents
Among her latest inventions, Eva has developed two notable patents. The first patent focuses on "Biomarkers predictive of predisposition to depression and response to treatment." This invention is designed to help identify individuals with a predisposition to recurrent depression, predict their responsiveness to therapy, and assess whether they have achieved remission following treatment. The second patent titled "Compositions and methods for identifying depressive disorders" provides novel compositions, kits, and methodologies for diagnosing major depressive disorder, thereby facilitating earlier and more accurate identification of this condition.
Career Highlights
Throughout her career, Eva has been affiliated with esteemed institutions such as Northwestern University and the University of Pennsylvania. Her work at these universities has significantly advanced the understanding and treatment of mental health issues, reflecting her dedication to research and innovation.
Collaborations
In her pursuit of groundbreaking solutions in mental health, Eva has collaborated with notable professionals in the field, including Fraser Aird and Brian Andrus. These collaborations have enriched her research and contributed to the successful development of her patented inventions.
Conclusion
Eva E Redei stands out as a pioneer in mental health innovation with her extensive portfolio of patents and collaborative efforts. Her inventions not only reflect her scientific expertise but also her passion for enhancing the lives of those affected by depressive disorders. As she continues her work, the impact of her innovations will undoubtedly resonate within the field of mental health for years to come.